Cell-Free Therapy White Papers
The Cell-Free Therapy Advantage Series
11 in-depth white papers covering the full science of Cell-Free Therapy.
The series is reviewed regularly. Most recent review: September 2026.
The Cell-Free Therapy Advantage Series
11 in-depth white papers covering the full science of Cell-Free Therapy.
The series is reviewed regularly. Most recent review: September 2026.
The whole scientific case for Cell-Free Therapy in one read, before the eleven papers that follow. Completed June 2026 (read the announcement).
Download PDFFrom paracrine signalling to environmental conditioning. The scientific foundation of Cell-Free Therapy.
Download PDFAutologous processing, quality control, and the regulatory framework that surrounds CFT manufacture.
Download PDFWhy Cell-Free Therapy is the next evolution of blood-derived treatment.
Download PDFMechanisms, evidence, and limits of EV-mediated CNS transit.
Download PDFWhy particle count is the wrong metric, and what actually determines biological potency.
Download PDFWhy the full cocktail outperforms single-factor and purified-fraction approaches.
Download PDFWhy your own biology is the best biology. The case for autologous over allogeneic.
Download PDFThe repeatability and biological banking advantage of a single draw.
Download PDFThe safety case for cell-free preparations.
Download PDF